Welcome to our dedicated page for Southstate Corporation SEC filings (Ticker: SSB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Credit-quality tables, CECL reserve swings, and net-interest margin math can turn SouthState鈥檚 filings into a 300-page maze. If you have ever asked, 鈥淲here do I find the SouthState quarterly earnings report 10-Q filing?鈥� or 鈥淲hat鈥檚 hidden in the latest SouthState insider trading Form 4 transactions?鈥� you already know the challenge.
Stock Titan solves it. Our AI reads every SouthState SEC document the moment it hits EDGAR, then condenses the essentials鈥攃apital ratios, loan portfolio shifts, deposit mix changes鈥攊nto plain language. Whether you need the SouthState annual report 10-K simplified, a real-time alert for SouthState Form 4 insider transactions, or an 8-K material events explained summary, the platform delivers answers, not page counts.
Jump straight to what matters:
- Instant highlights from each SouthState quarterly earnings report 10-Q filing鈥攖rack margin trends without spreadsheet gymnastics.
- AG真人官方-time dashboards of SouthState executive stock transactions Form 4 so you can monitor insider sentiment before the market reacts.
- Context-rich notes on every SouthState proxy statement executive compensation section, showing pay tied to return on assets and tangible book growth.
- One-click deep dives into SouthState 8-K material events鈥攎erger announcements, loan charge-offs, or dividend changes鈥攅xplained simply.
Analysts use these insights to compare quarter-over-quarter reserve builds, portfolio mix, and community-bank M&A impact. Portfolio managers flag unusual SouthState earnings report filing analysis within minutes. Individual investors rely on our AI for understanding SouthState SEC documents with AI, replacing hours of dense reading with clear, actionable points.
On 24 Jul 2025, SouthState Corporation (NYSE: SSB) filed an 8-K covering three key items:
- Item 2.02 鈥� Results of Operations: The Company issued a press release (Ex. 99.1) and slide deck (Ex. 99.2) with financial results for Q2-25; specific figures are not included in the filing. A conference call is scheduled for 25 Jul 2025 at 9:00 a.m. ET (dial-in +1 888-350-3899, passcode 4200408).
- Item 7.01 鈥� Reg FD: The same presentation will be used during the call and is furnished, not filed, thereby limiting liability under 搂18 of the Exchange Act.
- Item 8.01 鈥� Other Events: The Board raised the quarterly cash dividend 11% to $0.60/share (from $0.54). The dividend is payable 15 Aug 2025 to holders of record on 8 Aug 2025.
No financial tables or detailed earnings metrics are contained within the body of this 8-K; investors must review the attached exhibits for full results.
SouthState Corp (SSB) 鈥� Form 4 insider transaction
Director David R. Brooks reported the vesting and automatic conversion (Code M) of 267 restricted share units on 07/22/2025. The RSUs were granted on 01/22/2025 as part of prorated annual director fees and vested in full on 07/22/2025 at zero cost to the director. Following the transaction, Brooks' direct ownership rose to 52,707 common shares. No shares were sold and no derivative positions remain disclosed.
The filing is routine board-compensation housekeeping and is unlikely to influence SouthState鈥檚 valuation or trading dynamics.
SouthState Corp (SSB) 鈥� Form 4 insider transaction
Director David R. Brooks reported the vesting and automatic conversion (Code M) of 267 restricted share units on 07/22/2025. The RSUs were granted on 01/22/2025 as part of prorated annual director fees and vested in full on 07/22/2025 at zero cost to the director. Following the transaction, Brooks' direct ownership rose to 52,707 common shares. No shares were sold and no derivative positions remain disclosed.
The filing is routine board-compensation housekeeping and is unlikely to influence SouthState鈥檚 valuation or trading dynamics.
SouthState Corp (SSB) 鈥� Form 4 insider transaction
Director David R. Brooks reported the vesting and automatic conversion (Code M) of 267 restricted share units on 07/22/2025. The RSUs were granted on 01/22/2025 as part of prorated annual director fees and vested in full on 07/22/2025 at zero cost to the director. Following the transaction, Brooks' direct ownership rose to 52,707 common shares. No shares were sold and no derivative positions remain disclosed.
The filing is routine board-compensation housekeeping and is unlikely to influence SouthState鈥檚 valuation or trading dynamics.
Fennec Pharmaceuticals Inc. (FENC) 鈥� Form 144 filing discloses that insider Rostislav Raykov has notified the SEC of his intent to sell up to 10,000 common shares through Morgan Stanley Smith Barney on or after 03 July 2025. At the 30 June 2025 closing price used in the filing, the aggregate market value of the proposed sale is $86,102, equivalent to roughly 0.036 % of the 27.6 million shares outstanding.
The shares stem from recently vested restricted-stock grants acquired on 16 May 2025 (7,570 sh) and 30 June 2025 (2,430 sh). The filing also details that Raykov has already disposed of 46,667 shares between 4 April and 5 June 2025 for total gross proceeds of approximately $295,398.
Rule 144 notices do not guarantee execution, but repeated insider sales within a short window can influence market sentiment. Nevertheless, the cumulative volume over the past quarter plus the planned sale (鈮�56,667 shares) remains below 0.21 % of outstanding shares, suggesting limited dilution or supply pressure.